Once upon a prime: DCs shape cancer immunity.

Humans CD8-Positive T-Lymphocytes Dendritic Cells Neoplasms / pathology T-Lymphocytes, Cytotoxic Lymphocyte Activation Tumor Microenvironment
T cell priming antitumor immunity cancer immunotherapy cytotoxic T cells dendritic cells stimulatory signals

Journal

Trends in cancer
ISSN: 2405-8025
Titre abrégé: Trends Cancer
Pays: United States
ID NLM: 101665956

Informations de publication

Date de publication:
02 2023
Historique:
received: 31 08 2022
revised: 05 10 2022
accepted: 12 10 2022
pubmed: 11 11 2022
medline: 28 1 2023
entrez: 10 11 2022
Statut: ppublish

Résumé

Cytotoxic CD8

Identifiants

DOI: 10.1016/j.trecan.2022.10.006 PMID: 36357313
pubmed: 36357313
pii: S2405-8033(22)00229-1
doi: 10.1016/j.trecan.2022.10.006
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

172-184

Subventions

Organisme : NCI NIH HHS
ID : R37 CA273819
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests S.S. is an SAB member for Related Sciences, Arcus Biosciences, and Venn Therapeutics. S.S. is a cofounder of Danger Bio. S.S. is a consultant for TAKEDA, Merck, Tango Therapeutics, and Ribon Therapeutics and receives funding for unrelated projects from Leap Therapeutics.

Auteurs

Maria Zagorulya (M)

Department of Biology, MIT, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.

Stefani Spranger (S)

Department of Biology, MIT, Cambridge, MA 02139, USA; Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA; Ludwig Center at MIT's Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA. Electronic address: spranger@mit.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Once upon a prime: DCs shape cancer immunity.
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › Once upon a prime: DCs shape cancer immunity.
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Système phagocytaire mononucléé › Cellules dendritiques › Once upon a prime: DCs shape cancer immunity.
questionsmedicales.fr › Tumeurs › Once upon a prime: DCs shape cancer immunity.
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T cytotoxiques › Once upon a prime: DCs shape cancer immunity.
questionsmedicales.fr › Phénomènes du système immunitaire › Activation des lymphocytes › Once upon a prime: DCs shape cancer immunity.
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Microenvironnement cellulaire › Microenvironnement tumoral › Once upon a prime: DCs shape cancer immunity.